Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2007 Jun;66(6):754-63.
doi: 10.1136/ard.2006.062901. Epub 2007 Jan 18.

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

U A Walker  1 , A Tyndall, L Czirják, C Denton, D Farge-Bancel, O Kowal-Bielecka, U Müller-Ladner, C Bocelli-Tyndall, M Matucci-Cerinic
Affiliations
Multicenter Study

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

U A Walker et al. Ann Rheum Dis. 2007 Jun.

Abstract

Background: Systemic sclerosis (SSc) is a multisystem autoimmune disease, which is classified into a diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subset according to the skin involvement. In order to better understand the vascular, immunological and fibrotic processes of SSc and to guide its treatment, the EULAR Scleroderma Trials And Research (EUSTAR) group was formed in June 2004.

Aims and methods: EUSTAR collects prospectively the Minimal Essential Data Set (MEDS) on all sequential patients fulfilling the American College of Rheumatology diagnostic criteria in participating centres. We aimed to characterise demographic, clinical and laboratory characteristics of disease presentation in SSc and analysed EUSTAR baseline visits.

Results: In April 2006, a total of 3656 patients (1349 with dcSSc and 2101 with lcSSc) were enrolled in 102 centres and 30 countries. 1330 individuals had autoantibodies against Scl70 and 1106 against anticentromere antibodies. 87% of patients were women. On multivariate analysis, scleroderma subsets (dcSSc vs lcSSc), antibody status and age at onset of Raynaud's phenomenon, but not gender, were found to be independently associated with the prevalence of organ manifestations. Autoantibody status in this analysis was more closely associated with clinical manifestations than were SSc subsets.

Conclusion: dcSSc and lcSSc subsets are associated with particular organ manifestations, but in this analysis the clinical distinction seemed to be superseded by an antibody-based classification in predicting some scleroderma complications. The EUSTAR MEDS database facilitates the analysis of clinical patterns in SSc, and contributes to the standardised assessment and monitoring of SSc internationally.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Alamanos Y, Tsifetaki N, Voulgari P V, Siozos C, Tsamandouraki K, Alexiou G A.et al Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum 200534714–720. - PubMed
    1. Roberts‐Thomson P J, Jones M, Hakendorf P, Kencana Dharmapatni A A, Walker J G, MacFarlane J G.et al Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J 200131220–229. - PubMed
    1. Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991283366–371. - PubMed
    1. Czirjak L, Kiss C G, Lovei C, Suto G, Varju C, Fuzesi Z.et al Survey of Raynaud's phenomenon and systemic sclerosis based on a representative study of 10 000 south‐Transdanubian Hungarian inhabitants. Clin Exp Rheumatol 200523801–808. - PubMed
    1. Geirsson A J, Steinsson K, Guthmundsson S, Sigurthsson V. Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 199453502–505. - PMC - PubMed

Publication types

MeSH terms